Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q21874220)
Watch
English
Atara Biotherapeutics, Inc.
clinical-stage biotechnology company
Atara Biotherapeutics
Atara Bio
NASDAQ:ATRA
In more languages
edit
Statements
instance of
business
0 references
enterprise
0 references
public company
0 references
part of
NASDAQ Biotechnology Index
0 references
Russell 2000
0 references
industry
biotechnology
0 references
oncology
0 references
multiple sclerosis
0 references
autoimmune disease
0 references
Cellular therapy and transplantation
0 references
inception
2012
0 references
field of work
post-transplant lymphoproliferative disorder
0 references
immunotherapy
0 references
T-lymphocytes
0 references
Epstein–Barr virus
0 references
country
United States of America
0 references
legal form
public company
0 references
headquarters location
South San Francisco
0 references
stock exchange
Nasdaq
ticker symbol
ATRA
0 references
official website
http://www.atarabio.com/
language of work or name
English
0 references
Identifiers
Legal Entity Identifier
549300WBXUXZRE03MS38
0 references
ISNI
0000000474131708
1 reference
ROR ID
04h82wq77
retrieved
25 July 2020
Central Index Key
0001604464
0 references
Crunchbase organization ID
atara-biotherapeutics
1 reference
stated in
Crunchbase
reference URL
http://www.crunchbase.com/organization/atara-biotherapeutics
Golden ID
Atara_Biotherapeutics-VWRB854
1 reference
retrieved
10 September 2022
reference URL
https://golden.com/wiki/Atara_Biotherapeutics-VWRB854
GRID ID
grid.508098.c
1 reference
stated in
GRID Release 2020-06-29
Open Funder Registry funder ID
100016253
0 references
PermID
5037937603
0 references
ROR ID
04h82wq77
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit